ALIMP — Implanet SA Share News
0.000.00%
Last trade - 00:00- €26.60m
- €29.52m
- €12.47m
Brief: Implanet FY net loss narrows to 7.3 million euros
Brief: Implanet signs exclusive distribution partnership for Australia and New Zealand
Brief: Implanet's French patent office grants patent protecting Jazz Lock implant
Brief: Implanet announces global marketing clearance of New JAZZ FRAME
Brief: Implanet FY sales up 18 pct to 7.8 million euros
Brief: Implanet announces new European patent for Jazz platform
Brief: Implanet presents JAZZ band clinical results in hypokyphotic idiopathic scoliosis patients
Brief: Implanet successfully completes 6.9 million euros capital increase
Brief: Implanet launches capital increase of about 6.9 million euros
Brief: Implanet Q3 sales of 1.5 million euros
Brief: Implanet H1 revenue up to 4.1 million euros
Brief: Implanet successful first surgical procedures with new Jazz Lock Implant
Brief: Implanet obtains key US patent for JAZZ technological platform
Brief: Implanet issues convertible bonds with warrants attached for 250,000 euros
Brief: Implanet Q2 revenue of 2.1 million euro, up 23%
Brief: Implanet launches new JAZZ Claw implant
Brief: Implanet Q1 revenue rises 24% to 2.0 million euros
Brief: Implanet commences trading on OTCQX in the U.S.
Brief: Implanet receives green light to market JAZZ Lock implant